Which repairs can slow damage buildup across the body's tissues?

CROSS-DOMAIN TRANSFER, conditional: In a defined aging-human tissue, direct macrophage obstruction or contest over targets may cause consequential interruptions of completed corpse clearance and thereby sustain secondary injury. The frozen unexpected consequence remains a conditional ranking reversal: at sufficiently high physiological macrophage density, an achievable reduction in interference could outperform a specified TIM-4 attachment enhancement, whereas attachment enhancement would be more effective at sufficiently low density. Density alone does not establish this ordering. Under the assumed response F=aN/(1+ahN+cM), compare attachment enhancement a→qa, q>1, with interference relief c→rc, 0≤r<1, at the same positive N and M and unchanged h. For c>0 and qr<1, interference relief produces greater throughput when cM>(q−1)/(1−qr), attachment enhancement wins below that threshold, and they tie at equality. Whether physiological densities and achievable exposures span both regimes is an unverified assumption. The equation predicts increasing total clearance with recruitment at fixed N and increasing, saturating per-cell clearance at fixed N/M. A clearance advantage could improve SPV_1 only through separately demonstrated reduction of continuing injury and preservation of tissue function.

Record donor age, sex, diseases, medications and macrophage state. First measure relevant human-tissue density ranges and spatial distributions. Independently vary N and M, separating fixed-N and fixed-N/M paths. Directly image contacts that interrupt encounter, capture, internalization or subsequent processing; quantify their duration, recurrence and attributable lost clearance time. Mere contact at high density is insufficient. Measure accessible volume, target depletion and accessibility, motility, encounter frequency, capture probability, oxygen, nutrients, viability, activation, metabolic flux, intracellular processing and readiness for another target. Cross calibrated attachment enhancement with selective relief of the observed interruption. At the same N and M, interference relief should recover consequential lost clearance time and increase completed destruction beyond changes explained by ordinary access, resources, capture or intrinsic handling. Relief of the obstruction itself may improve access; distinguish that causal change from unrelated changes in baseline accessibility rather than requiring access to remain invariant by definition. Use reversible or orthogonal perturbations where feasible and verify their specificity. Define a completed-removal event for the chosen target using observed uptake and processing of specified material; separately report any residual refractory fraction. Calibrate q and r independently and prospectively compare the two interventions below and above the crossover when c>0 and qr<1. Compare per-cell and total clearance within each density. Continued benefit from attachment enhancement, a positive fitted c or a throughput crossover alone does not prove direct interference. If qr≥1, the stated pure-parameter interventions have no crossover. If interventions also alter h, geometry, access or cell state, use measured changes to test the full response rather than applying the simple threshold. Validate predictions on held-out density combinations and during serial processing; allow rejection of constant parameters or the quasi-steady approximation. Observe contacts over hours and processing over days within demonstrated culture viability. Measure corpse production, extracellular residence, uptake, intracellular stock, export and destruction products separately. Faster uptake may increase storage, and faster destruction may leave an injury process unchanged. After a selective clearance rescue, test secondary injury, tissue function and post-transient damage slopes directly against attachment restoration, compartment-specific lysosomal repair, measured metabolic-demand reduction and appropriate controls. Failure of selective rescue at relevant densities challenges direct interference in that regime; failure of the crossover constrains the comparative prediction without excluding interference generally. Failure to reduce injury despite increased destruction limits the downstream aging claim.

Skin is the proposed first system, not an established dominant tissue. First establish a physiologically justified reversible-stress range and a reproducible target population capable of sustained tissue-relevant recovery. Define the recovery endpoint and observation interval before confirmatory testing, including delayed death; do not identify a human responder subgroup solely from a favorable intervention outcome. Use low macrophage densities at which direct observation finds no material interference. Cross selective TIM-4 restoration, target-cell-restricted lysosomal repair and selective ingestion prevention with vehicle and pathway controls. Use two mechanistically distinct ingestion perturbations where feasible, but establish their selectivity rather than assuming it. Validate precontact fate indicators in randomized matched protected cohorts; the same ingested cell's counterfactual recovery cannot be observed. Measure attachment, completed internalization and ingestion-attributable irreversible loss separately. Quantify primary and delayed irreversible death, genuine corpse production, extracellular residence, uptake, intracellular retention and destruction, together with inflammation, repair and durable tissue function. Measure cell replacement, lineage contribution where feasible and functional compensation so that preserved cell number is not equated with preserved tissue performance. Define dominance prospectively over a specified population and interval, for example as more than half of gross continuing functional-cell loss attributable to ingestion; this is an operational proposal, not an observed biological threshold. Report that attribution separately from net functional loss and account for interacting causes rather than summing overlapping losses. The focal prediction is a TIM-4-restoration-by-ingestion interaction: increased attachment produces additional irreversible loss from the validated recoverable population when ingestion is permitted, and selective prevention preserves durable function. The stronger frozen consequence additionally requires fewer genuine extracellular corpses and worse net tissue preservation, with ingestion-related functional costs exceeding beneficial clearance, including delayed inflammation and repair. Target-only, conditioned-medium and secretion measurements must test whether apparent protection instead follows reduced initial injury or altered macrophage output. Comparable genuine corpse clearance must be verified during selective target protection; protection does not itself predict more corpses. Test the contextual p38–TIM-4 link separately through p38 activity, TIM-4 surface abundance, attachment and internalization, with selective perturbation and TIM-4 interruption or rescue. MerTK effects cannot establish this link. For the repair explanation, demonstrate target-cell lysosomal injury, the proposed recognition or recovery state, compartment-restricted repair and restoration before irreversible commitment; follow membrane integrity, leakage, acidity, recognition signals and function. Exclude macrophage exposure and independently altered macrophage processing. A repair benefit remaining when ingestion is prevented can support primary-injury prevention or another compatible route. Match initial stress, oxygen, nutrients and measured metabolic flux where feasible. Observe contact over hours and recovery over days, extending repeated exposure only within demonstrated culture viability; these are proposed windows, not adequate chronic-human follow-up. Failure to find recoverable targets, ingestion-caused death, TIM-4 dependence, quantitative dominance or net harm constrains the corresponding claim under the adequately perturbed conditions. Net benefit from attachment restoration can coexist with a smaller harmful ingestion pathway. Subsequently compare post-transient damage and functional trajectories with attachment restoration, compartment-specific lysosomal repair, measured metabolic-demand reduction and appropriate controls.

Altered protein chemistry may block breakdown until chemical repair enables disposal predicts instead: Begin with sequence-matched modified, unmodified and pre-corrected proteins with analytically resolved modification sites, linkage and stereoisomers. Use standards and sample-handling controls to distinguish biological modification from changes introduced during preparation. In defined proteolytic conditions, compare direct effects with conformation, aggregation and accessibility held comparable; separately measure total effects when modification is allowed to change folding or aggregation, since these can mediate chemical resistance. Measure modification formation and backbone turnover independently to distinguish modification-driven retention from residence-driven modification. Identify a matching endogenous pool at functionally consequential abundance in older-human donor cells, initially proposed dermal fibroblasts, recording age, sex, disease and treatment. Define consequential abundance through a measurable effect on specified tissue-relevant function at endogenous exposure rather than merely enrichment in old material. Specify whether the pool is cytosolic, lysosomal, extracellular-matrix-associated or corpse-associated. Cross verified lysosomal integrity, leakage, acidity, delivery and ordinary proteolytic capacity with active versus catalytically inactive repair enzyme at comparable delivery, localization, substrate access and cofactor exposure. Avoid artificial overload and independent toxicity; measure metabolic flux, synthesis and stress responses. The focal result is selective persistence of the modified pool despite restored ordinary processing, followed by verified chemical correction that causally increases destruction of the same labeled backbone. Establish the correction-mediated step using analytically characterized pre-corrected substrate: remove the repair enzyme and reaction components before a matched degradation challenge, with sham-treated modified controls, so a direct effect of the enzyme or carryover on proteases cannot alone explain rescue. Confirm the relevant result in endogenous material; cell-free rescue does not establish cellular delivery. Measure correction yield, remaining modified forms and the accessible repairable fraction. Track intact modified and corrected backbones, degradation products, export, cell loss, redistribution, new synthesis and label recycling across original cells, macrophages and medium. Loss of an isomer signal, catalytic dependence or temporal order alone is insufficient. For the uptake prediction, directly trace the same identified modified backbone from corpse cargo into macrophages, verify restored ordinary macrophage processing, and test persistent material and correction-enabled destruction within that compartment. Fibroblast retention and cell-free resistance do not establish macrophage resistance. If the pool never reaches macrophages, investigate access and trafficking. Observe chemical conversion over hours and turnover over days or longer within demonstrated viability. Comparable degradation after ordinary processing restoration weakens the proposed chemical limitation for that substrate. Correction that improves function without increasing backbone destruction supports a compatible direct-repair interpretation rather than the parent degradation chain. Only after establishing the causal sequence should repeated exposure compare post-transient accumulation, functional injury and harms with membrane repair, uptake restoration and measured metabolic-demand reduction.

Skin lipid receptors may trigger internal signals that reduce damage in distant tissues predicts instead: Use paired older-human skin explants with recorded age, sex, anatomical site, baseline barrier condition, disease and treatment, coupled initially to a specified human endothelial model. The proposed initial scope is viable older-donor skin with reproducible receptor engagement and measurable baseline secretory activity, connected to remote cells with a prospectively defined damage-formation endpoint. Identify L, R, responding skin-cell type, endogenous K and the remote damage class before confirmatory mechanism testing. Define eligibility independently of a favorable confirmatory outcome. Confirm the identified chain in separate material. Compare chemically defined active A and inactive B with matched vehicle, coverage and hydration. Repeatedly establish equivalence of relevant physical permeability, water loss, irritant flux, lipid organization, viability and local injury throughout exposure and receptor manipulation, using justified model-specific bounds and intervals. Define each permeability probe and compartment. Measure penetration and concentration-time profiles of each formulation constituent separately; equivalent physical permeability does not imply equal biologically active ligand exposure or receptor engagement in A and B. If the needed physical separation cannot be maintained, the independent receptor contribution remains unresolved rather than disproved. Cross skin-restricted receptor interruption with rescue. Deplete or block K and restore it at its measured physiological exposure. Include sham depletion, recovery measurements and an orthogonal mediator-blocking approach where feasible; quantify whether depletion also removes bound lipid, metabolites, carrier proteins or other active medium components. Receptor interruption can change uptake or metabolism of the formulation, so quantify those changes rather than interpreting receptor dependence alone as endogenous mediation. Trace applied L, other constituents, metabolites, tissue binding, reservoirs and delayed release; reproduce measured remote concentration-time profiles in direct-exposure controls. Establish endogenous K identity and origin separately from formulation-derived active metabolites. The focal mechanistic prediction is R-dependent endogenous K output reaching the remote compartment at sufficient exposure, with reduced formation of the specified damage and preserved function. Selective K interruption removes its attributable protection, and physiological add-back restores that component after physical and direct-exposure explanations are accounted for. Add-back demonstrates sufficiency only in the tested background, not universal sufficiency. Incomplete exposure accounting or nonselective depletion retains a mixed or unresolved mechanism. For the stronger ranking, directly compare A, barrier-matched B, a defined measured-demand-reduction arm M, and vehicle or appropriate usual-care controls, adding rival handles where feasible. Here M names the comparator arm, whereas M in IH_02 denotes macrophage density. Fix population, baseline impairment, remote vulnerability, exposures, maintenance, damage class and post-transient interval prospectively. For the selected deterioration slope, positive means worsening. Define Δ_A=b_A−b_M and Δ_B=b_B−b_M in the same damage-per-time units. The frozen strict hypothesis H_strict is Δ_A<0 AND Δ_B≥0. Evaluate both zero-threshold contrasts jointly with prespecified uncertainty control: an upper confidence bound below zero for Δ_A supports A's strict superiority; a lower bound at or above zero for Δ_B supports B's non-superiority under the stated inferential assumptions. An interval crossing zero leaves the corresponding ordering unresolved. Exact equality cannot generally be established by finite noisy observations, and nonsignificance does not establish Δ_B≥0. Separately define positive practical margins δ_A and δ_B before testing. A practical hypothesis H_practical may be Δ_A<−δ_A AND Δ_B>−δ_B: A exceeds the chosen meaningful-benefit margin, while a benefit of at least δ_B for B is excluded. This allows a small negative Δ_B and therefore does not establish H_strict. Conversely, H_strict allows an arbitrarily small negative Δ_A and therefore does not establish meaningful superiority for A. Assess practical bounds against their own thresholds and report strict ordering, meaningful A benefit and exclusion of meaningful B benefit separately. Symmetric equivalence, if tested, is another claim and does not prove Δ_B≥0. Call a margin clinically meaningful only if its clinical interpretation is justified; a culture-assay threshold alone supplies an experimental relevance margin. No margin value is established here. R interruption or K depletion should remove A's mediator-attributable protection or comparative component, and rescue should restore it; the direction of every residual A-versus-M contrast is not fixed if other pathways also act. Measure formation, removal, cell loss, composition and function separately. Observe signaling over hours and injury over days, repeating only within verified viability. Failure of strict or practical ranking limits that specific claim even if endogenous receptor-mediated protection exists. Human systemic delivery, maintenance and multisystem trajectories require subsequent evidence.

SCOUT from stereochemistry and protein-aging chemistry, conditional: In a defined aging-human tissue, spontaneous post-synthesis aspartyl isomerization or racemization may produce a functionally consequential endogenous protein pool whose chemistry causes resistance to ordinary degradation. The frozen unexpected consequence remains: restoration of lysosomal membrane integrity or corpse uptake could leave disposal of this material incomplete. For an accessible and demonstrably repairable subset, protein-L-isoaspartate O-methyltransferase-dependent correction could enable subsequent destruction of the same protein backbone and reduce continuing accumulation. Modified-protein enrichment alone cannot establish this direction: prolonged residence may cause modification, modification may prolong residence, or both may occur. Correction preceding destruction is also insufficient without evidence that correction enables it. Persistence specifically attributed to chemical resistance after macrophage uptake requires the identified modified protein to enter macrophages and resist their processing machinery. Uptake can fail to affect an inaccessible or trafficking-limited pool through other routes. Direct correction of intact protein may independently improve function without accelerating destruction. The retained parent mechanism is correction-enabled degradation; superiority over the focal handles or measured metabolic-demand reduction and multisystem sufficiency remain separate conditional claims.

Use standards and sample-handling controls to distinguish biological modification from changes introduced during preparation. In defined proteolytic conditions, compare direct effects with conformation, aggregation and accessibility held comparable; separately measure total effects when modification is allowed to change folding or aggregation, since these can mediate chemical resistance. Measure modification formation and backbone turnover independently to distinguish modification-driven retention from residence-driven modification. Identify a matching endogenous pool at functionally consequential abundance in older-human donor cells, initially proposed dermal fibroblasts, recording age, sex, disease and treatment. Define consequential abundance through a measurable effect on specified tissue-relevant function at endogenous exposure rather than merely enrichment in old material. Specify whether the pool is cytosolic, lysosomal, extracellular-matrix-associated or corpse-associated. Cross verified lysosomal integrity, leakage, acidity, delivery and ordinary proteolytic capacity with active versus catalytically inactive repair enzyme at comparable delivery, localization, substrate access and cofactor exposure. Avoid artificial overload and independent toxicity; measure metabolic flux, synthesis and stress responses. The focal result is selective persistence of the modified pool despite restored ordinary processing, followed by verified chemical correction that causally increases destruction of the same labeled backbone. Establish the correction-mediated step using analytically characterized pre-corrected substrate: remove the repair enzyme and reaction components before a matched degradation challenge, with sham-treated modified controls, so a direct effect of the enzyme or carryover on proteases cannot alone explain rescue. Confirm the relevant result in endogenous material; cell-free rescue does not establish cellular delivery. Measure correction yield, remaining modified forms and the accessible repairable fraction. Track intact modified and corrected backbones, degradation products, export, cell loss, redistribution, new synthesis and label recycling across original cells, macrophages and medium. Loss of an isomer signal, catalytic dependence or temporal order alone is insufficient. For the uptake prediction, directly trace the same identified modified backbone from corpse cargo into macrophages, verify restored ordinary macrophage processing, and test persistent material and correction-enabled destruction within that compartment. Fibroblast retention and cell-free resistance do not establish macrophage resistance. If the pool never reaches macrophages, investigate access and trafficking. Observe chemical conversion over hours and turnover over days or longer within demonstrated viability. Comparable degradation after ordinary processing restoration weakens the proposed chemical limitation for that substrate. Correction that improves function without increasing backbone destruction supports a compatible direct-repair interpretation rather than the parent degradation chain. Only after establishing the causal sequence should repeated exposure compare post-transient accumulation, functional injury and harms with membrane repair, uptake restoration and measured metabolic-demand reduction.

Skin is the proposed first system, not an established dominant tissue. First establish a physiologically justified reversible-stress range and a reproducible target population capable of sustained tissue-relevant recovery. Define the recovery endpoint and observation interval before confirmatory testing, including delayed death; do not identify a human responder subgroup solely from a favorable intervention outcome. Use low macrophage densities at which direct observation finds no material interference. Cross selective TIM-4 restoration, target-cell-restricted lysosomal repair and selective ingestion prevention with vehicle and pathway controls. Use two mechanistically distinct ingestion perturbations where feasible, but establish their selectivity rather than assuming it. Validate precontact fate indicators in randomized matched protected cohorts; the same ingested cell's counterfactual recovery cannot be observed. Measure attachment, completed internalization and ingestion-attributable irreversible loss separately. Quantify primary and delayed irreversible death, genuine corpse production, extracellular residence, uptake, intracellular retention and destruction, together with inflammation, repair and durable tissue function. Measure cell replacement, lineage contribution where feasible and functional compensation so that preserved cell number is not equated with preserved tissue performance. Define dominance prospectively over a specified population and interval, for example as more than half of gross continuing functional-cell loss attributable to ingestion; this is an operational proposal, not an observed biological threshold. Report that attribution separately from net functional loss and account for interacting causes rather than summing overlapping losses. The focal prediction is a TIM-4-restoration-by-ingestion interaction: increased attachment produces additional irreversible loss from the validated recoverable population when ingestion is permitted, and selective prevention preserves durable function. The stronger frozen consequence additionally requires fewer genuine extracellular corpses and worse net tissue preservation, with ingestion-related functional costs exceeding beneficial clearance, including delayed inflammation and repair. Target-only, conditioned-medium and secretion measurements must test whether apparent protection instead follows reduced initial injury or altered macrophage output. Comparable genuine corpse clearance must be verified during selective target protection; protection does not itself predict more corpses. Test the contextual p38–TIM-4 link separately through p38 activity, TIM-4 surface abundance, attachment and internalization, with selective perturbation and TIM-4 interruption or rescue. MerTK effects cannot establish this link. For the repair explanation, demonstrate target-cell lysosomal injury, the proposed recognition or recovery state, compartment-restricted repair and restoration before irreversible commitment; follow membrane integrity, leakage, acidity, recognition signals and function. Exclude macrophage exposure and independently altered macrophage processing. A repair benefit remaining when ingestion is prevented can support primary-injury prevention or another compatible route. Match initial stress, oxygen, nutrients and measured metabolic flux where feasible. Observe contact over hours and recovery over days, extending repeated exposure only within demonstrated culture viability; these are proposed windows, not adequate chronic-human follow-up. Failure to find recoverable targets, ingestion-caused death, TIM-4 dependence, quantitative dominance or net harm constrains the corresponding claim under the adequately perturbed conditions. Net benefit from attachment restoration can coexist with a smaller harmful ingestion pathway. Subsequently compare post-transient damage and functional trajectories with attachment restoration, compartment-specific lysosomal repair, measured metabolic-demand reduction and appropriate controls.

Macrophage obstruction may slow corpse clearance and sustain tissue injury predicts instead: Use older-human donor macrophages in a defined three-dimensional dermal system with verified irreversibly dead targets of specified identity and size. Record donor age, sex, diseases, medications and macrophage state. First measure relevant human-tissue density ranges and spatial distributions. Independently vary N and M, separating fixed-N and fixed-N/M paths. Directly image contacts that interrupt encounter, capture, internalization or subsequent processing; quantify their duration, recurrence and attributable lost clearance time. Mere contact at high density is insufficient. Measure accessible volume, target depletion and accessibility, motility, encounter frequency, capture probability, oxygen, nutrients, viability, activation, metabolic flux, intracellular processing and readiness for another target. Cross calibrated attachment enhancement with selective relief of the observed interruption. At the same N and M, interference relief should recover consequential lost clearance time and increase completed destruction beyond changes explained by ordinary access, resources, capture or intrinsic handling. Relief of the obstruction itself may improve access; distinguish that causal change from unrelated changes in baseline accessibility rather than requiring access to remain invariant by definition. Use reversible or orthogonal perturbations where feasible and verify their specificity. Define a completed-removal event for the chosen target using observed uptake and processing of specified material; separately report any residual refractory fraction. Calibrate q and r independently and prospectively compare the two interventions below and above the crossover when c>0 and qr<1. Compare per-cell and total clearance within each density. Continued benefit from attachment enhancement, a positive fitted c or a throughput crossover alone does not prove direct interference. If qr≥1, the stated pure-parameter interventions have no crossover. If interventions also alter h, geometry, access or cell state, use measured changes to test the full response rather than applying the simple threshold. Validate predictions on held-out density combinations and during serial processing; allow rejection of constant parameters or the quasi-steady approximation. Observe contacts over hours and processing over days within demonstrated culture viability. Measure corpse production, extracellular residence, uptake, intracellular stock, export and destruction products separately. Faster uptake may increase storage, and faster destruction may leave an injury process unchanged. After a selective clearance rescue, test secondary injury, tissue function and post-transient damage slopes directly against attachment restoration, compartment-specific lysosomal repair, measured metabolic-demand reduction and appropriate controls. Failure of selective rescue at relevant densities challenges direct interference in that regime; failure of the crossover constrains the comparative prediction without excluding interference generally. Failure to reduce injury despite increased destruction limits the downstream aging claim.

Skin lipid receptors may trigger internal signals that reduce damage in distant tissues predicts instead: Use paired older-human skin explants with recorded age, sex, anatomical site, baseline barrier condition, disease and treatment, coupled initially to a specified human endothelial model. The proposed initial scope is viable older-donor skin with reproducible receptor engagement and measurable baseline secretory activity, connected to remote cells with a prospectively defined damage-formation endpoint. Identify L, R, responding skin-cell type, endogenous K and the remote damage class before confirmatory mechanism testing. Define eligibility independently of a favorable confirmatory outcome. Confirm the identified chain in separate material. Compare chemically defined active A and inactive B with matched vehicle, coverage and hydration. Repeatedly establish equivalence of relevant physical permeability, water loss, irritant flux, lipid organization, viability and local injury throughout exposure and receptor manipulation, using justified model-specific bounds and intervals. Define each permeability probe and compartment. Measure penetration and concentration-time profiles of each formulation constituent separately; equivalent physical permeability does not imply equal biologically active ligand exposure or receptor engagement in A and B. If the needed physical separation cannot be maintained, the independent receptor contribution remains unresolved rather than disproved. Cross skin-restricted receptor interruption with rescue. Deplete or block K and restore it at its measured physiological exposure. Include sham depletion, recovery measurements and an orthogonal mediator-blocking approach where feasible; quantify whether depletion also removes bound lipid, metabolites, carrier proteins or other active medium components. Receptor interruption can change uptake or metabolism of the formulation, so quantify those changes rather than interpreting receptor dependence alone as endogenous mediation. Trace applied L, other constituents, metabolites, tissue binding, reservoirs and delayed release; reproduce measured remote concentration-time profiles in direct-exposure controls. Establish endogenous K identity and origin separately from formulation-derived active metabolites. The focal mechanistic prediction is R-dependent endogenous K output reaching the remote compartment at sufficient exposure, with reduced formation of the specified damage and preserved function. Selective K interruption removes its attributable protection, and physiological add-back restores that component after physical and direct-exposure explanations are accounted for. Add-back demonstrates sufficiency only in the tested background, not universal sufficiency. Incomplete exposure accounting or nonselective depletion retains a mixed or unresolved mechanism. For the stronger ranking, directly compare A, barrier-matched B, a defined measured-demand-reduction arm M, and vehicle or appropriate usual-care controls, adding rival handles where feasible. Here M names the comparator arm, whereas M in IH_02 denotes macrophage density. Fix population, baseline impairment, remote vulnerability, exposures, maintenance, damage class and post-transient interval prospectively. For the selected deterioration slope, positive means worsening. Define Δ_A=b_A−b_M and Δ_B=b_B−b_M in the same damage-per-time units. The frozen strict hypothesis H_strict is Δ_A<0 AND Δ_B≥0. Evaluate both zero-threshold contrasts jointly with prespecified uncertainty control: an upper confidence bound below zero for Δ_A supports A's strict superiority; a lower bound at or above zero for Δ_B supports B's non-superiority under the stated inferential assumptions. An interval crossing zero leaves the corresponding ordering unresolved. Exact equality cannot generally be established by finite noisy observations, and nonsignificance does not establish Δ_B≥0. Separately define positive practical margins δ_A and δ_B before testing. A practical hypothesis H_practical may be Δ_A<−δ_A AND Δ_B>−δ_B: A exceeds the chosen meaningful-benefit margin, while a benefit of at least δ_B for B is excluded. This allows a small negative Δ_B and therefore does not establish H_strict. Conversely, H_strict allows an arbitrarily small negative Δ_A and therefore does not establish meaningful superiority for A. Assess practical bounds against their own thresholds and report strict ordering, meaningful A benefit and exclusion of meaningful B benefit separately. Symmetric equivalence, if tested, is another claim and does not prove Δ_B≥0. Call a margin clinically meaningful only if its clinical interpretation is justified; a culture-assay threshold alone supplies an experimental relevance margin. No margin value is established here. R interruption or K depletion should remove A's mediator-attributable protection or comparative component, and rescue should restore it; the direction of every residual A-versus-M contrast is not fixed if other pathways also act. Measure formation, removal, cell loss, composition and function separately. Observe signaling over hours and injury over days, repeating only within verified viability. Failure of strict or practical ranking limits that specific claim even if endogenous receptor-mediated protection exists. Human systemic delivery, maintenance and multisystem trajectories require subsequent evidence.

SCOUT from cutaneous pharmacology and lipid receptor biology, conditional: In a prospectively defined subset of aging humans, a topical lipid L may activate a receptor R in a defined viable skin-cell population, alter a receptor-regulated endogenous mediator K and thereby reduce formation of a specified remote damage class independently of equivalent physical barrier restoration. L, R, K, the responding cells and the remote damage class remain unresolved identities. The frozen unexpected consequence is retained as a separate strict comparative hypothesis: under a specified population, exposure, maintenance regime and post-transient interval, receptor-active formulation A has a lower deterioration slope than a defined metabolic-demand-reduction comparator M, while barrier-equivalent receptor-inactive formulation B does not: b_A<b_M and b_B≥b_M. Practical effect-margin hypotheses are distinct and cannot substitute for this ordering. Receptor dependence alone entails neither version. Physical barrier repair, lysosomal repair, efferocytosis restoration and metabolic-demand reduction may provide compatible or interacting benefits. The proposed endogenous-mediator pathway must be distinguished from direct remote action of formulation constituents and metabolites, including receptor-regulated production or transport of active metabolites in skin. If sustained endogenous signaling reduces remote damage formation while preserving function, it could improve corresponding SPV_1 components. Neither the pathway, strict ordering, practical magnitude nor whole-human benefit is established.

The proposed initial scope is viable older-donor skin with reproducible receptor engagement and measurable baseline secretory activity, connected to remote cells with a prospectively defined damage-formation endpoint. Identify L, R, responding skin-cell type, endogenous K and the remote damage class before confirmatory mechanism testing. Define eligibility independently of a favorable confirmatory outcome. Confirm the identified chain in separate material. Compare chemically defined active A and inactive B with matched vehicle, coverage and hydration. Repeatedly establish equivalence of relevant physical permeability, water loss, irritant flux, lipid organization, viability and local injury throughout exposure and receptor manipulation, using justified model-specific bounds and intervals. Define each permeability probe and compartment. Measure penetration and concentration-time profiles of each formulation constituent separately; equivalent physical permeability does not imply equal biologically active ligand exposure or receptor engagement in A and B. If the needed physical separation cannot be maintained, the independent receptor contribution remains unresolved rather than disproved. Cross skin-restricted receptor interruption with rescue. Deplete or block K and restore it at its measured physiological exposure. Include sham depletion, recovery measurements and an orthogonal mediator-blocking approach where feasible; quantify whether depletion also removes bound lipid, metabolites, carrier proteins or other active medium components. Receptor interruption can change uptake or metabolism of the formulation, so quantify those changes rather than interpreting receptor dependence alone as endogenous mediation. Trace applied L, other constituents, metabolites, tissue binding, reservoirs and delayed release; reproduce measured remote concentration-time profiles in direct-exposure controls. Establish endogenous K identity and origin separately from formulation-derived active metabolites. The focal mechanistic prediction is R-dependent endogenous K output reaching the remote compartment at sufficient exposure, with reduced formation of the specified damage and preserved function. Selective K interruption removes its attributable protection, and physiological add-back restores that component after physical and direct-exposure explanations are accounted for. Add-back demonstrates sufficiency only in the tested background, not universal sufficiency. Incomplete exposure accounting or nonselective depletion retains a mixed or unresolved mechanism. For the stronger ranking, directly compare A, barrier-matched B, a defined measured-demand-reduction arm M, and vehicle or appropriate usual-care controls, adding rival handles where feasible. Here M names the comparator arm, whereas M in IH_02 denotes macrophage density. Fix population, baseline impairment, remote vulnerability, exposures, maintenance, damage class and post-transient interval prospectively. For the selected deterioration slope, positive means worsening. Define Δ_A=b_A−b_M and Δ_B=b_B−b_M in the same damage-per-time units. The frozen strict hypothesis H_strict is Δ_A<0 AND Δ_B≥0. Evaluate both zero-threshold contrasts jointly with prespecified uncertainty control: an upper confidence bound below zero for Δ_A supports A's strict superiority; a lower bound at or above zero for Δ_B supports B's non-superiority under the stated inferential assumptions. An interval crossing zero leaves the corresponding ordering unresolved. Exact equality cannot generally be established by finite noisy observations, and nonsignificance does not establish Δ_B≥0. Separately define positive practical margins δ_A and δ_B before testing. A practical hypothesis H_practical may be Δ_A<−δ_A AND Δ_B>−δ_B: A exceeds the chosen meaningful-benefit margin, while a benefit of at least δ_B for B is excluded. This allows a small negative Δ_B and therefore does not establish H_strict. Conversely, H_strict allows an arbitrarily small negative Δ_A and therefore does not establish meaningful superiority for A. Assess practical bounds against their own thresholds and report strict ordering, meaningful A benefit and exclusion of meaningful B benefit separately. Symmetric equivalence, if tested, is another claim and does not prove Δ_B≥0. Call a margin clinically meaningful only if its clinical interpretation is justified; a culture-assay threshold alone supplies an experimental relevance margin. No margin value is established here. R interruption or K depletion should remove A's mediator-attributable protection or comparative component, and rescue should restore it; the direction of every residual A-versus-M contrast is not fixed if other pathways also act. Measure formation, removal, cell loss, composition and function separately. Observe signaling over hours and injury over days, repeating only within verified viability. Failure of strict or practical ranking limits that specific claim even if endogenous receptor-mediated protection exists. Human systemic delivery, maintenance and multisystem trajectories require subsequent evidence.

Skin is the proposed first system, not an established dominant tissue. First establish a physiologically justified reversible-stress range and a reproducible target population capable of sustained tissue-relevant recovery. Define the recovery endpoint and observation interval before confirmatory testing, including delayed death; do not identify a human responder subgroup solely from a favorable intervention outcome. Use low macrophage densities at which direct observation finds no material interference. Cross selective TIM-4 restoration, target-cell-restricted lysosomal repair and selective ingestion prevention with vehicle and pathway controls. Use two mechanistically distinct ingestion perturbations where feasible, but establish their selectivity rather than assuming it. Validate precontact fate indicators in randomized matched protected cohorts; the same ingested cell's counterfactual recovery cannot be observed. Measure attachment, completed internalization and ingestion-attributable irreversible loss separately. Quantify primary and delayed irreversible death, genuine corpse production, extracellular residence, uptake, intracellular retention and destruction, together with inflammation, repair and durable tissue function. Measure cell replacement, lineage contribution where feasible and functional compensation so that preserved cell number is not equated with preserved tissue performance. Define dominance prospectively over a specified population and interval, for example as more than half of gross continuing functional-cell loss attributable to ingestion; this is an operational proposal, not an observed biological threshold. Report that attribution separately from net functional loss and account for interacting causes rather than summing overlapping losses. The focal prediction is a TIM-4-restoration-by-ingestion interaction: increased attachment produces additional irreversible loss from the validated recoverable population when ingestion is permitted, and selective prevention preserves durable function. The stronger frozen consequence additionally requires fewer genuine extracellular corpses and worse net tissue preservation, with ingestion-related functional costs exceeding beneficial clearance, including delayed inflammation and repair. Target-only, conditioned-medium and secretion measurements must test whether apparent protection instead follows reduced initial injury or altered macrophage output. Comparable genuine corpse clearance must be verified during selective target protection; protection does not itself predict more corpses. Test the contextual p38–TIM-4 link separately through p38 activity, TIM-4 surface abundance, attachment and internalization, with selective perturbation and TIM-4 interruption or rescue. MerTK effects cannot establish this link. For the repair explanation, demonstrate target-cell lysosomal injury, the proposed recognition or recovery state, compartment-restricted repair and restoration before irreversible commitment; follow membrane integrity, leakage, acidity, recognition signals and function. Exclude macrophage exposure and independently altered macrophage processing. A repair benefit remaining when ingestion is prevented can support primary-injury prevention or another compatible route. Match initial stress, oxygen, nutrients and measured metabolic flux where feasible. Observe contact over hours and recovery over days, extending repeated exposure only within demonstrated culture viability; these are proposed windows, not adequate chronic-human follow-up. Failure to find recoverable targets, ingestion-caused death, TIM-4 dependence, quantitative dominance or net harm constrains the corresponding claim under the adequately perturbed conditions. Net benefit from attachment restoration can coexist with a smaller harmful ingestion pathway. Subsequently compare post-transient damage and functional trajectories with attachment restoration, compartment-specific lysosomal repair, measured metabolic-demand reduction and appropriate controls.

Macrophage obstruction may slow corpse clearance and sustain tissue injury predicts instead: Use older-human donor macrophages in a defined three-dimensional dermal system with verified irreversibly dead targets of specified identity and size. Record donor age, sex, diseases, medications and macrophage state. First measure relevant human-tissue density ranges and spatial distributions. Independently vary N and M, separating fixed-N and fixed-N/M paths. Directly image contacts that interrupt encounter, capture, internalization or subsequent processing; quantify their duration, recurrence and attributable lost clearance time. Mere contact at high density is insufficient. Measure accessible volume, target depletion and accessibility, motility, encounter frequency, capture probability, oxygen, nutrients, viability, activation, metabolic flux, intracellular processing and readiness for another target. Cross calibrated attachment enhancement with selective relief of the observed interruption. At the same N and M, interference relief should recover consequential lost clearance time and increase completed destruction beyond changes explained by ordinary access, resources, capture or intrinsic handling. Relief of the obstruction itself may improve access; distinguish that causal change from unrelated changes in baseline accessibility rather than requiring access to remain invariant by definition. Use reversible or orthogonal perturbations where feasible and verify their specificity. Define a completed-removal event for the chosen target using observed uptake and processing of specified material; separately report any residual refractory fraction. Calibrate q and r independently and prospectively compare the two interventions below and above the crossover when c>0 and qr<1. Compare per-cell and total clearance within each density. Continued benefit from attachment enhancement, a positive fitted c or a throughput crossover alone does not prove direct interference. If qr≥1, the stated pure-parameter interventions have no crossover. If interventions also alter h, geometry, access or cell state, use measured changes to test the full response rather than applying the simple threshold. Validate predictions on held-out density combinations and during serial processing; allow rejection of constant parameters or the quasi-steady approximation. Observe contacts over hours and processing over days within demonstrated culture viability. Measure corpse production, extracellular residence, uptake, intracellular stock, export and destruction products separately. Faster uptake may increase storage, and faster destruction may leave an injury process unchanged. After a selective clearance rescue, test secondary injury, tissue function and post-transient damage slopes directly against attachment restoration, compartment-specific lysosomal repair, measured metabolic-demand reduction and appropriate controls. Failure of selective rescue at relevant densities challenges direct interference in that regime; failure of the crossover constrains the comparative prediction without excluding interference generally. Failure to reduce injury despite increased destruction limits the downstream aging claim.

Altered protein chemistry may block breakdown until chemical repair enables disposal predicts instead: Begin with sequence-matched modified, unmodified and pre-corrected proteins with analytically resolved modification sites, linkage and stereoisomers. Use standards and sample-handling controls to distinguish biological modification from changes introduced during preparation. In defined proteolytic conditions, compare direct effects with conformation, aggregation and accessibility held comparable; separately measure total effects when modification is allowed to change folding or aggregation, since these can mediate chemical resistance. Measure modification formation and backbone turnover independently to distinguish modification-driven retention from residence-driven modification. Identify a matching endogenous pool at functionally consequential abundance in older-human donor cells, initially proposed dermal fibroblasts, recording age, sex, disease and treatment. Define consequential abundance through a measurable effect on specified tissue-relevant function at endogenous exposure rather than merely enrichment in old material. Specify whether the pool is cytosolic, lysosomal, extracellular-matrix-associated or corpse-associated. Cross verified lysosomal integrity, leakage, acidity, delivery and ordinary proteolytic capacity with active versus catalytically inactive repair enzyme at comparable delivery, localization, substrate access and cofactor exposure. Avoid artificial overload and independent toxicity; measure metabolic flux, synthesis and stress responses. The focal result is selective persistence of the modified pool despite restored ordinary processing, followed by verified chemical correction that causally increases destruction of the same labeled backbone. Establish the correction-mediated step using analytically characterized pre-corrected substrate: remove the repair enzyme and reaction components before a matched degradation challenge, with sham-treated modified controls, so a direct effect of the enzyme or carryover on proteases cannot alone explain rescue. Confirm the relevant result in endogenous material; cell-free rescue does not establish cellular delivery. Measure correction yield, remaining modified forms and the accessible repairable fraction. Track intact modified and corrected backbones, degradation products, export, cell loss, redistribution, new synthesis and label recycling across original cells, macrophages and medium. Loss of an isomer signal, catalytic dependence or temporal order alone is insufficient. For the uptake prediction, directly trace the same identified modified backbone from corpse cargo into macrophages, verify restored ordinary macrophage processing, and test persistent material and correction-enabled destruction within that compartment. Fibroblast retention and cell-free resistance do not establish macrophage resistance. If the pool never reaches macrophages, investigate access and trafficking. Observe chemical conversion over hours and turnover over days or longer within demonstrated viability. Comparable degradation after ordinary processing restoration weakens the proposed chemical limitation for that substrate. Correction that improves function without increasing backbone destruction supports a compatible direct-repair interpretation rather than the parent degradation chain. Only after establishing the causal sequence should repeated exposure compare post-transient accumulation, functional injury and harms with membrane repair, uptake restoration and measured metabolic-demand reduction.